Richard Feachem

Last updated

Sir Richard George Andrew Feachem, KBE, FREng [1] (born 10 April 1947) [2] is professor of global health at both the University of California, San Francisco, and the University of California, Berkeley, and director of the Global Health Group at UCSF Global Health Sciences. He is also a visiting professor at the University of London and an honorary professor at the University of Queensland.

Contents

Past work

External videos
Richard Feachem crop 2012 CHF HIV AIDS 112.jpg
Nuvola apps kaboodle.svg Sir Richard Feachem & others, "The Evolution of HIV/AIDS Therapies: A Conversation", 2012, Chemical Heritage Foundation

From 2002 to 2007, Sir Richard served as founding executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Under Secretary General of the United Nations. During this time, the Global Fund grew from scratch to become the world's largest health financing institution for developing countries, with assets of US$11 billion, supporting 450 programmes in 136 countries.

From 1999 to 2002, Professor Feachem was the founding director of the Institute for Global Health at UCSF and UC Berkeley. From 1995 until 1999, Dr. Feachem was director for Health, Nutrition and Population at the World Bank. Previously (1989–1995), he was Dean of the London School of Hygiene and Tropical Medicine. [3] Professor Feachem served as Chairman of the Foundation Council of the Global Forum for Health Research; Board member and Treasurer of the International AIDS Vaccine Initiative; Council Member of Voluntary Service Overseas; and on numerous other boards and committees. He was a member of the Commission on Macroeconomics and Health and Governance in Africa. He currently serves on the Commission on Investing in Health. He has worked in international health and development for 40 years and has published extensively on public health, health policy and development finance.

Professor Feachem holds a Doctor of Science degree in Medicine from the University of London, and a PhD in Environmental Health from the University of New South Wales. In 2007, he was awarded an Honorary Doctorate in Engineering by the University of Birmingham. He is a Fellow [4] of the Royal Academy of Engineering [5] and an Honorary Fellow of the Faculty of Public Health Medicine of the Royal College of Physicians and of the American Society of Tropical Medicine and Hygiene. In 2002, he was elected to membership of the Institute of Medicine of the US National Academy of Sciences. Sir Richard was knighted by Her Majesty Queen Elizabeth II in 2007. [6]

Current work

In October 2007, Sir Richard founded "The Global Health Group" within UCSF Global Health Sciences. The Global Health Group is an “Action Tank” dedicated to bringing major new paradigms in global health through to large scale action. This entails analysis, policy formulation, and consensus building, followed by intensive collaborations with individual developing countries to achieve large-scale application of the new ideas. The Global Health Group is supported by grants from the Bill & Melinda Gates Foundation, ExxonMobil, and numerous other sources.

The Global Health Group has three Initiatives; the Malaria Elimination Initiative (MEI), the Private Sector Healthcare Initiative (PSHi) and the Evidence to Policy Initiative (E2Pi). The MEI is dedicated to shrinking the malaria map by eliminating malaria from the endemic margins inwards. Under Sir Richard's leadership, a global Malaria Elimination Group (MEG) has been established. MEG had its first meeting in California in March 2008, its second in South Africa in October 2008, and its third in Switzerland in April 2009. Hainan, China, in December 2009; Huatulco, Mexico, in November 2010; Zanzibar, Tanzania, November 2011 and December 2012 in Al Ain, UAE. MEG VIII will return to California in October 2013. The MEI team is based in San Francisco and Southern Africa and has made a significant contribution to policy, science and practice in malaria elimination. The geographic focus of the work is primarily Asia Pacific and Southern Africa.

The Global Health Group, in collaboration with the Australian Government, the University of Queensland, and WHO launched the Asia Pacific Malaria Elimination Network (APMEN) in Brisbane in February 2009. APMEN brings together 14 eliminating countries from the Asia Pacific Region to share experiences and co-ordinate policy.

The second front of Feachem's Global Health Group is the PSHi, which focuses on studying and enhancing the role of the private sector in healthcare delivery in developing countries. Of particular interest is the model now known as the Public-Private Investment Partnership (PPIP) in which governments enter into partnerships with private consortia to finance and rebuild major health infrastructure and to provide clinical services over a period of decades.

The Global Health Group has joined with PwC to document pioneering PPIPs in that Spain, Lesotho, Latin America, S.E. Asia, and elsewhere. A second model of special interest to the Global Health Group is Clinical Social Franchising. The fifth Compendium or Atlas on this topic was recently published by the Global Health Group.

The third Initiative of the Global Health Group is E2Pi, which provides rapid turnaround policy options, based on comprehensive evidence synthesis, concerning current issues in global health. Clients have included the Gates Foundation, The Global Fund, GAVI, and UNITAID. The E2Pi is also playing a major role in the Commission in Investing in Health.

Sir Richard and Winnie Mpanju-Shumbusho were both senior authors of a 2019 report in The Lancet about committing to the eradication of malaria across the world by 2030. [7] [8]

Personal

Dr. Feachem lives in Alameda, California, with his wife Neelam Sekhri Feachem, the CEO of the Healthcare Redesign Group.

Related Research Articles

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in San Francisco, California

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

<span class="mw-page-title-main">The Global Fund to Fight AIDS, Tuberculosis and Malaria</span> International organization

The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing and partnership organization that aims to "attract, leverage and invest additional resources to end the epidemics of HIV/AIDS, tuberculosis and malaria to support attainment of the Sustainable Development Goals established by the United Nations". This multistakeholder international organization maintains its secretariat in Geneva, Switzerland. The organization began operations in January 2002. Microsoft founder Bill Gates was one of the first donors to provide seed money for the partnership. From January 2006 it has benefited from certain US Privileges, Exemptions, and Immunities under executive order 13395, which conferred International Organizations Immunities Act status on it.

Africa Fighting Malaria (AFM) was an NGO based in Washington D.C., United States and South Africa which stated that it "seeks to educate people about the scourge of Malaria and the political economy of malaria control". The organization generally "promotes market based solutions and economic freedom as the best ways to ensure improved welfare and longer life expectancy in poor countries", according to their financial statement. Founded in 2000 during the Stockholm Negotiations on Persistent Organic Pollutants, AFM's original focus was the promotion of a public health exemption for the insecticide DDT for malaria control. According to their website, last updated in 2011, their mission was to "make malaria control more transparent, responsive and effective by holding public institutions accountable for funding and implementing effective, integrated and country-driven malaria control policies."

<span class="mw-page-title-main">Mark R. Dybul</span> American diplomat

Mark R. Dybul is an American diplomat, physician and medical researcher. He served as the executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria from 2012 until 2017. Since 2021, he has been the CEO of Renovaro Biosciences. Since 2022, he is the Executive Chairman of Purpose Life Sciences.

Haile Debas is an Eritrean physician and academic administrator at the University of California, San Francisco.

<span class="mw-page-title-main">William R. Steiger</span> American government official

William Raymond Steiger is a Public Policy Fellow at the Wilson Center in Washington, D.C.. He served as Chief of Staff at the United States Agency for international Development from 2017 to 2021. Previously, Steiger was the chief program officer at Pink Ribbon Red Ribbon, an organization affiliated with the George W. Bush Institute, which works to reduce deaths from cervical cancer and breast cancer in low- and middle-income countries. He was the Special Assistant to the Secretary for International Affairs and the Director of the Office of Global Health Affairs at the U.S. Department of Health and Human Services (DHHS) during the George W. Bush Administration, with a portfolio that included HIV/AIDS, malaria, avian flu and pandemic-influenza preparedness.

<span class="mw-page-title-main">Awa Marie Coll-Seck</span> Senegalese infectious diseases specialist and politician

Awa Marie Coll-Seck is as Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.

<span class="mw-page-title-main">Eric Goosby</span> American public health official

Eric Goosby is an American public health official, currently serving as the UN Special Envoy on Tuberculosis. Goosby previously served as the United States Global AIDS Coordinator from 2009 until mid-November 2013. In the role, Goosby directed the U.S. strategy for addressing HIV around the world and led President Obama's implementation of the President's Emergency Plan for AIDS Relief (PEPFAR). Goosby was sworn in during June 2009 and resigned in November 2013, taking a position as a professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy, a collaboration between UCSF and the University of California, Berkeley.

Jack Chow is an American professor of public health. He holds the position of Distinguished Service Professor at Carnegie Mellon University Heinz College. Chow held a number of global public health offices including positions as the first Assistant Director-General of the World Health Organization on HIV/AIDS, Tuberculosis, and Malaria, Special Representative of the U.S. Secretary of State on Global HIV/AIDS and Deputy Assistant Secretary of State for Health and Science. This was a first - "first U.S. diplomat of ambassador rank appointed to a public health mission."

<span class="mw-page-title-main">Agnes Binagwaho</span> Rwandan pediatrician

Agnes Binagwaho is a Rwandan Politian, pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.

<span class="mw-page-title-main">Michel Kazatchkine</span> Michel Kazatchkine* - Special Envoy for HIV/AIDS in Eastern Europe and Central Asia

Michel Kazatchkine is a French physician, diplomat and advocate who is best known for his work in international AIDS treatment issues. From February 2007 to March 2012 he was director of The Global Fund to Fight AIDS, Tuberculosis and Malaria. On July 20, 2012, UN Secretary-General Ban Ki-moon appointed him as his United Nations Special Envoy for HIV/AIDS in Eastern Europe and Central Asia.

The UCSF School of Medicine is the medical school of the University of California, San Francisco and is located at the base of Mount Sutro on the Parnassus Heights campus in San Francisco, California. Founded in 1864 by Hugh Toland, it is the oldest medical school in California and in the western United States. U.S. News & World Report ranked the school third in research training and second in primary care training; it is the only medical school in the nation to rank among the top three in both categories. Six members of the UCSF faculty have received the Nobel Prize in Physiology or Medicine and five have received the National Medal of Science.

<span class="mw-page-title-main">Thomas J. Coates</span>

Thomas J. Coates is the Director of the multi-campus University of California Global Health Institute, a UC-wide initiative established to improve health and reduce the burden of disease throughout the world. He is Professor Emeritus at the UCLA David Geffen School of Medicine and Founding Director of the UCLA Center for World Health, a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health, He has conducted extensive research in the realm of HIV and is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA and Distinguished Professor of Medicine. Health-related behavior is of particular interest to Coates. Throughout his career as a health expert, his theory-based research has been focused on interventions aimed at reducing risks and threats to health

Dr. Winnie Mpanju-Shumbusho is a Tanzanian paediatrician and public health leader who until December 31, 2015, served as World Health Organization (WHO) Assistant Director General for HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases based in Geneva, Switzerland. From 2016 to 2019, she served as board chair of RBM Partnership To End Malaria. Before joining WHO in 1999, Mpanju-Shumbusho was Director General of The East, Central and Southern African Health Community (ECSA-HC) formerly known as the Commonwealth Regional Health Community for East, Central and Southern Africa (CRHC-ECSA).

John S. Greenspan was an academic dentist/scientist and university administrator. His degrees and diplomas include BSc, BDS, Ph.D., FRCPath, FDSRCS (Eng). He was the Director-Emeritus of the AIDS Research Institute at the University of California, San Francisco (UCSF). He was also the founding Director of the UCSF AIDS Specimen Bank (1982-2017) and of the UCSF Oral AIDS Center (1986–2005).

Susan Kleppner Folkman is an American psychologist, author, and emerita professor of medicine at the University of California at San Francisco (UCSF). She is internationally recognized for her contributions to the field of psychological stress and coping. Her 1984 book Stress, Appraisal and Coping alongside Richard S. Lazarus, is the most widely cited academic book in its field, and the 17th most cited book in social science.

<span class="mw-page-title-main">Kalipso Chalkidou</span> Public health academic and researcher

Kalipso Chalkidou is the Head of Health Finance at The Global Fund to Fight AIDS, Tuberculosis and Malaria and a Visiting Professor at Imperial College London. Previously she was Director of Global Health Policy at the Center for Global Development and Professor of Practice in Global Health at Imperial College London. Her research considers how local expertise can inform the allocation of scientific and healthcare resources.

<span class="mw-page-title-main">Julia Adler-Milstein</span> Professor of Medicine

Julia Adler-Milstein is a Professor of Medicine and Director of the Center for Clinical Informatics and Improvement Research at the University of California, San Francisco. In 2019, she was named a Member of the National Academy of Medicine.

Helen L. Smits was a health policy influencer and advocate in the United States, and lent her voice to several healthcare initiatives abroad. Most notably, she was a recipient of the Fulbright scholarship and served under the Carter and Clinton administrations. She also held positions in government organizations including the National Institutes of Health (NIH) and Healthcare Financing Administration.

Rifat Atun is a British Physician and academic who currently serves as the Harvard University Professor of Global Health Systems and Director of the Health System Innovation Lab at Harvard University. He is one of the most important figures in the contemporary study of comparative health systems and healthcare innovation and has made substantial contributions to health systems theory, health systems reform, and innovation in health systems.

References

  1. ↑ "List of Fellows". Archived from the original on 8 June 2016. Retrieved 16 October 2014.
  2. ↑ "FEACHEM, Sir Richard (George Andrew)". Who's Who 2015. A & C Black. November 2014. Retrieved 10 April 2015.
  3. ↑ "Distinguished Alumni". www.lshtm.ac.uk. Archived from the original on 1 December 2008.
  4. ↑ "List of Fellows". Archived from the original on 8 June 2016. Retrieved 16 October 2014.
  5. ↑ "List of Fellows". Archived from the original on 8 June 2016. Retrieved 16 October 2014.
  6. ↑ "Press Releases - News Room - Media Center - The Global Fund to Fight AIDS, Tuberculosis and Malaria". www.theglobalfund.org. Archived from the original on 5 July 2010.
  7. ↑ "Malaria 'Could Be Wiped Out In 30 Years' – Here's How". HuffPost UK. 9 September 2019. Retrieved 8 October 2019.
  8. ↑ Feachem, Richard G A; Chen, Ingrid; Akbari, Omar; Bertozzi-Villa, Amelia; Bhatt, Samir; Binka, Fred; Boni, Maciej F; Buckee, Caroline; Dieleman, Joseph; Dondorp, Arjen; Eapen, Alex (September 2019). "Malaria eradication within a generation: ambitious, achievable, and necessary" (PDF). The Lancet. 394 (10203): 1056–1112. doi:10.1016/S0140-6736(19)31139-0. PMID   31511196. S2CID   202044083. Archived from the original (PDF) on 7 November 2020. Retrieved 28 August 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.